In 2015, Brie Code was working at leading video game company Ubisoft as lead artificial intelligence programmer when she realized that many people she knew – about half, by her estimation – found video games boring. [Read more…] about Trend: Harnessing digital tech to improve mental health and wellness
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring this time nine scientific reports and industry developments to help promote lifelong brain and mental health.
“… venting likely doesn’t soothe anger as much as augment it. That’s because encouraging people to act out their anger makes them relive it in their bodies, strengthening the neural pathways for anger and making it easier to get angry the next time around. Studies on venting anger (without effective feedback), whether online or verbally, have also found it to be generally unhelpful … To get out of that, you can ask the person to step back and help you reframe your experience by asking, “How should I think about this differently?” or “What should I do in this situation?”
“The new company would find it pushing well beyond its current mindfulness focus to, “provide the full spectrum of proven, effective virtual support – from mindfulness and meditation, to text-based behavioral health coaching, to video-based therapy and psychiatry – for all types of patient populations.”
12 good tips for students and everyone else
Their independent review concludes that “given the lack of evidence of a robust and meaningful clinical benefit and the known safety signal, we recommend against offering this agent to patients with Alzheimer’s dementia (mild or otherwise) or mild cognitive impairment.”
A strong call to “learn how this regulatory failure occurred and to ensure that it doesn’t occur again”
Addressing the ongoing controversy about conservatorships, a USC Professor of Law, Psychology, and Psychiatry shares a great article to debunk these all-too-common myths
If you have not encountered the “Linda brain teaser” before, please give it a try! If you have, you’ll enjoy the new paper titled Tversky and Kahneman’s Cognitive Illusions: Who Can Solve Them, and Why?
Fascinating approach to gait training.
Neuralink vs. Paradromics vs. non-invasive platforms — quite a stimulating space to track
Wishing you and yours a happy and healthy back-to-school and month of September,
The SharpBrains Team
Blue Note Therapeutics, Inc., today announced the closing of a Series A financing round of $26.25 million. Proceeds will allow the company to scale the organization and fund near-term clinical trials of its lead prescription digital therapeutic (PDT), which will potentially improve the treatment of cancer. The capital will also support the development of Blue Note’s pipeline assets. The Series A financing was led by JAZZ Venture Partners and joined by Summer VC. [Read more…] about Blue Note Therapeutics raises $26M to help treat cancer-related distress via cognitive behavioral stress management (CBSM)
The FDA granted Minneapolis-based NightWare a De Novo clearance on Friday for its Apple Watch and iPhone app designed to improve the sleep quality of those experiencing nightmare disorder and nightmares related to PTSD. [Read more…] about FDA grants clearance for NightWare app designed to reduce PTSD-related nightmares
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring 13 fascinating brain research findings, useful resources–and a brain teaser to test your attention skills.
#1. Good news of the month: Elders today are in significantly better shape–physically and cognitively–than three decades ago
#2. A distinction WITH a difference: Actual, sustained practice–not mere knowledge–is needed to harness neuroplasticity and improve cognition over time
#3. “Be mindful that with the rapid changes we are experiencing, our brains are going through accelerated learning. Our brains get tired just as our bodies would if we ran a marathon without training.” How COVID-related stress can disrupt your brain circuits and nine tips to prevent it
#6. Which is why we look forward to seeing 9,000+ students, plus their many teachers and administrators, further develop their unique brains and minds in years ahead: Helping shape the future of lifelong learning via SEK Education Group
#7. “… it would certainly be premature to suggest that moving to a high altitude state would improve a child’s ADHD symptoms. However, the findings highlight the value of keeping an open mind in efforts to understand the development of ADHD and the role natural environments may play in potentially alleviating it.” Study finds surprising correlation between states’ elevation and ADHD prevalence
#9. Time to start paying serious attention to the brain/ cognitive side effects of common medications. Anticholinergic drugs found to significantly increase risk of cognitive decline, especially among those with Alzheimer’s Disease biomarkers or genetic predisposition
#10. Fascinating: “After a 14-day training period … visuospatial skills improved by 40%. This increase in visuospatial ability was shown to be directly responsible for a reduction in motion sickness by 51% in the simulator … and a 58% reduction in the on-road trial.” Study: Self-driving cars will increase motion sickness…unless we retrain our brains to improve visuospatial skills
#11. Behavioral health and neuroplasticity meet big pharma to hopefully address a huge need. Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia
#12. Neuralink: Thumbs up or down?
#13. Brain teaser: Did you notice the numerical error as it happened? If not, feel free to go back and find it now 🙂
Wishing you a safe and healthy October,
Alvaro Fernandez and the SharpBrains Team
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. [Read more…] about Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia